Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients

SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months

Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2

Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers.